Evidence map›Paper›PMID 35603751›Full record

ArticleJournal of attention disorders2022

State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents, 2016 to 2019.

Melissa L Danielson, Joseph R Holbrook, Rebecca H Bitsko, Kimberly Newsome, Sana N Charania, Russell F McCord, Michael D Kogan, Stephen J Blumberg

Abstract read
In one paragraph

Article in Journal of attention disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Comorbid ADHD and Pediatric Sickle Cell Disease: Prevalence and Risk Factors.Journal of clinical psychology in medical settings · 2025
    Article
  11. Timing of Medication Treatment in Children 3-5-Years-old with ADHD: A PEDSnet Study.medRxiv : the preprint server for health sciences · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Diagnosis and Treatment of ADHD in the Pediatric Population.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Melissa L DanielsonNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-9461-0341
Joseph R HolbrookNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Rebecca H BitskoNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kimberly NewsomeNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sana N CharaniaNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Russell F McCordCenter for State, Tribal, Local, and Territorial Support, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Michael D KoganMaternal and Child Health Bureau, Health Resources and Services Administration, Rockville, MD, USA.
Stephen J BlumbergNational Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States in 2016 to 2019.

methodThis study used the National Survey of Children's Health to produce national and state-level estimates of lifetime diagnosis and current ADHD among all children aged 3 to 17 years (

resultsThe state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%. Among children with current ADHD, state-level estimates of ADHD medication usage ranged from 37.8% to 81.4%, and state-level estimates of behavioral treatment ranged from 38.8% to 61.8%.

conclusionThere was substantial state-level variation for indicators of ADHD diagnosis and associated treatment. These state-level results can be used by policymakers, public health practitioners, health care providers, and other stakeholders to help address the service needs of children with ADHD in their states.

Indexed as

Attention Deficit Disorder with HyperactivityAdolescentBehavior TherapyChildChild HealthHumansParentsPrevalenceUnited StatesADHDbehavior therapychildrendiagnosismedication

Identifiers

PMID35603751
PMCPMC9489617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.